My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Medipharm Labs Corp (OP:MEDIF)

0.0458 -0.0038 (-7.66%)

Streaming Delayed Price Updated: 2:42 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medipharm Labs Corp

< Previous 1 2 3 4 5 Next >

Cannabis Stock Gainers And Losers From August 4, 2023 ↗

August 04, 2023

Via Benzinga

MediPharm Delivers Cannabis Clinical Trial Material To US Research Partner And Provides Update On FDA Status ↗

August 01, 2023

MediPharm Labs Corp. (OTCQB: MEDIF) (TSX:LABS) (FSE:MLZ) has made its first delivery to the United States, and has completed the US FDA drug API manufacturer inspection at the company's Barrie, Ontario...

Via Benzinga

Cannabis Stock Gainers And Losers From July 25, 2023 ↗

July 25, 2023

Via Benzinga

Cannabis Stock Movers For August 3, 2023 ↗

August 03, 2023

Via Benzinga

Leadership Shake-Ups Across Several Weed Companies: Who Got The Top Jobs? ↗

July 05, 2023

As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the marijuana

Via Benzinga

Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems ↗

June 26, 2023

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) announced the extension of its existing strategic manufacturing agreement with Medipharm Labs Inc. (OTCQB: MEDIF) for the commercialization of...

Via Benzinga

MediPharm Labs Awarded Payment Of $9.8M By Ontario Court Of Justice ↗

July 27, 2022

MediPharm Labs Corp.

Via Benzinga

Marijuana Stock Movers For August 2, 2023 ↗

August 02, 2023

Via Benzinga

The Canadian Cannabis Report - Monday, May 22 ↗

May 22, 2023

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 16 stocks.

Via Talk Markets

MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA ↗

May 15, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced financial results for Q1 2023, revealing EBITDA growth over the past two years and a significant reduction in losses to CA$2.1...

Via Benzinga

Marijuana Stock Movers For August 1, 2023 ↗

August 01, 2023

Via Benzinga

The Canadian Cannabis Report - Monday, April 14 ↗

April 17, 2023

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks.

Via Talk Markets

MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30% ↗

April 13, 2023

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabis Inc.'s (OTCQB: VVCIF) operations follow

Via Benzinga

Cannabis Stock Movers For July 24, 2023 ↗

July 24, 2023

Via Benzinga

The Canadian Cannabis Report - Monday, April 10 ↗

April 10, 2023

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks.

Via Talk Markets

MediPharm Labs FY22 Revenue Grows Slightly To $16.3M ↗

March 31, 2023

MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021.

Via Benzinga

Cannabis Stock Movers For July 20, 2023 ↗

July 20, 2023

Via Benzinga

MediPharm Labs Shareholders Approve Merger With VIVO Cannabis ↗

March 22, 2023

MediPharm Labs Corp.

Via Benzinga

Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit ↗

March 21, 2023

Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian appeals court is set to rule on allowing businesses and farmers to...

Via Benzinga

MediPharm Labs To Acquire VIVO Cannabis ↗

December 22, 2022

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE: MLZ) and VIVO Cannabis Inc.

Via Benzinga

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

December 22, 2022

Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets...

Via Newsfile

Topics Cannabis

The Canadian Cannabis Report - Monday, Dec. 19 ↗

December 19, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, Nov.28 ↗

November 28, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, Nov. 21 ↗

November 21, 2022

The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

MediPharm Touts Strong Q3 Revenue Growth, Continues To Expand Internationally ↗

November 14, 2022

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced on Monday its financial results for the three months ended Sept. 30, 2022.

Via Benzinga

The Canadian Cannabis Report - Monday, Nov. 14 ↗

November 14, 2022

The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, Aug. 29 ↗

August 29, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, Aug. 15 ↗

August 15, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details ↗

August 15, 2022

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) Q2 2022 revenue declined 14%, to CA$4.36 million ($3,37 million), compared to revenue of CA$5.07 million in Q2 2021.

Via Benzinga

The Canadian Cannabis Report - Monday, Aug. 1 ↗

August 01, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.